Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 1
Submit an article Journal homepage
202
Views
12
CrossRef citations to date
0
Altmetric
Original

Cyclin-dependent kinase inhibitor seliciclib shows in vitro activity in diffuse large B-cell lymphomas

Katia Lacrima Laboratory of Experimental Oncology, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
,
Andrea Rinaldi Laboratory of Experimental Oncology, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
,
Sara Vignati Laboratory of Experimental Oncology, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
,
Vittoria Martin Anatomic Pathology Unit, University of Insubria, Ospedale di Circolo, Varese, Italy
,
Maria Grazia Tibiletti Anatomic Pathology Unit, University of Insubria, Ospedale di Circolo, Varese, Italy
,
Gianluca Gaidano Division of Haematology, Department of Clinical and Experimental Medicine and IRCAD, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
,
Carlo V. Catapano Laboratory of Experimental Oncology, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
&
Francesco Bertoni Laboratory of Experimental Oncology, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland; Experimental Haematology, Barts, London, UKCorrespondence[email protected]
, MD show all
Pages 158-167 | Received 22 Aug 2006, Accepted 23 Sep 2006, Published online: 01 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Prithviraj Bose, Gary L Simmons & Steven Grant. (2013) Cyclin-dependent kinase inhibitor therapy for hematologic malignancies. Expert Opinion on Investigational Drugs 22:6, pages 723-738.
Read now
Jan Molinsky, Magdalena Klanova, Michal Koc, Lenka Beranova, Ladislav Andera, Zdenka Ludvikova, Martina Bohmova, Zdenka Gasova, Miroslav Strnad, Robert Ivanek, Marek Trneny, Emanuel Necas, Jan Zivny & Pavel Klener. (2013) Roscovitine sensitizes leukemia and lymphoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Leukemia & Lymphoma 54:2, pages 372-380.
Read now
Ibrahim T Aldoss, Tsewang Tashi & Apar Kishor Ganti. (2009) Seliciclib in malignancies. Expert Opinion on Investigational Drugs 18:12, pages 1957-1965.
Read now
Shireen Kassam & Silvia Montoto. (2008) Oncologic, Endocrine & Metabolic Emerging drugs in B-cell non-Hodgkin's lymphoma. Expert Opinion on Emerging Drugs 13:2, pages 323-343.
Read now

Articles from other publishers (8)

Chiara Tarantelli and & Francesco Bertoni. 2023. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies 444 456 .
Yuxin Zhuang, Jinxin Che, Meijuan Wu, Yu Guo, Yongjin Xu, Xiaowu Dong & Haiyan Yang. (2022) Altered pathways and targeted therapy in double hit lymphoma. Journal of Hematology & Oncology 15:1.
Crossref
Forum Kayastha, Noah B. Herrington, Bandish Kapadia, Anirban Roychowdhury, Nahid Nanaji, Glen E. Kellogg & Ronald B. Gartenhaus. (2022) Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma. Molecular Medicine 28:1.
Crossref
Nobumoto Watanabe & Hiroyuki Osada. 2017. Bioprobes. Bioprobes 11 35 .
Yun Dai, Shuang Chen, Liang Yi & Minhui Xu. 2013. Trends in Stem Cell Proliferation and Cancer Research. Trends in Stem Cell Proliferation and Cancer Research 591 654 .
Andrea Rinaldi, Maurilio Ponzoni, Silvia Uccella, Davide Rossi, Gianluca Gaidano, Fabio Facchetti, Giancarlo Pruneri, Maria Grazia Tibiletti, Carlo Capella, Emanuele Zucca, Claudio Doglioni, Carlo Catapano & Francesco Bertoni. (2011) In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR‐ABL inhibitors in lymphomas . Hematological Oncology 29:3, pages 164-166.
Crossref
Douglas W. McMillin, Jake Delmore, Joseph Negri, Leutz Buon, Hannah M. Jacobs, Jacob Laubach, Jana Jakubikova, Melissa Ooi, Patrick Hayden, Robert Schlossman, Nikhil C. Munshi, Christoph Lengauer, Paul G. Richardson, Kenneth C. Anderson & Constantine S. Mitsiades. (2011) Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications. British Journal of Haematology 152:4, pages 420-432.
Crossref
Yun Dai & Steven Grant. 2009. Myeloma Therapy. Myeloma Therapy 331 363 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.